activity
20112025
most citedAn information-theoretic Phase I/II design for molecularly targeted agents that does not require an assumption of monotonicity

37 citations · 75 across the 30 of their papers we have counts for

collaborators
Showing 2021 · stat.APShow all

1 paper · 2 filters

stat.AP2021

Dose Finding Studies for Therapies with Late-Onset Toxicities: A Comparison Study of Designs

Helen Barnett, Oliver Boix, Dimintris Kontos +1

An objective of phase I dose-finding trials is to find the maximum tolerated dose; the dose with a particular risk of toxicity. Frequently, this risk is assessed across the first c…